138 related articles for article (PubMed ID: 6221642)
1. Inhibition of thromboxane formation prevents endotoxin-induced renal fibrin deposition in jaundiced rats.
Westwick J; Fletcher MS; Kakkar VV
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():83-91. PubMed ID: 6221642
[No Abstract] [Full Text] [Related]
2. Endotoxin, prostaglandins and renal fibrin deposition in obstructive jaundice.
Fletcher MS; Westwick J; Kakkar VV
Br J Surg; 1982 Oct; 69(10):625-9. PubMed ID: 6751458
[TBL] [Abstract][Full Text] [Related]
3. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
Ito T; Ogawa K; Sakai K; Watanabe J; Satake T; Kayama N; Hiraku S; Naito J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():245-51. PubMed ID: 6221531
[No Abstract] [Full Text] [Related]
4. Effects of a specific thromboxane synthetase inhibitor in equine endotoxaemia.
Semrad SD; Moore JN
Res Vet Sci; 1987 Sep; 43(2):137-42. PubMed ID: 3317581
[TBL] [Abstract][Full Text] [Related]
5. Do prostacyclin and thromboxane play a role in endotoxic shock?
Webb PJ; Westwick J; Scully MF; Zahavi J; Kakkar VV
Br J Surg; 1981 Oct; 68(10):720-4. PubMed ID: 7025959
[TBL] [Abstract][Full Text] [Related]
6. Chronic thromboxane synthase inhibition prevents fructose-induced hypertension.
Galipeau D; Arikawa E; Sekirov I; McNeill JH
Hypertension; 2001 Oct; 38(4):872-6. PubMed ID: 11641301
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of endogenous thromboxane synthesis by exogenous prostacyclin during endotoxemia in conscious sheep.
Flynn JT; Demling RH
Adv Shock Res; 1982; 7():199-207. PubMed ID: 6753534
[TBL] [Abstract][Full Text] [Related]
8. Formation of thromboxane B2 by platelets and concentrations of thromboxane B2 and 6-keto-prostaglandin F1 alpha in plasma after acute ethanol ingestion.
Kangasaho M; Hillbom M; Kaste M; Wuorela H; Vapaatalo H
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():223-8. PubMed ID: 6303086
[No Abstract] [Full Text] [Related]
9. Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
Ogawa K; Sakai K; Ito T; Watanabe J; Satake T
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():371-6. PubMed ID: 6221548
[No Abstract] [Full Text] [Related]
10. Role of activated platelets in endotoxin-induced DIC in rats.
Ito T; Asai F; Oshima T; Kobayashi S
Thromb Res; 1990 Aug; 59(4):735-47. PubMed ID: 2080492
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin and thromboxane levels during cardiac ischemia in dogs.
Prosdocimi M; Tessari F; Finesso M; Gorio A; Dejana E; Languino LR; Del Maschio A; de Gaetano G
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():93-6. PubMed ID: 3159235
[No Abstract] [Full Text] [Related]
12. Enzyme immunoassay of thromboxane B2 and 6-keto-prostaglandin F1 alpha as a substitute for radioimmunoassay.
Yamamoto S; Hayashi Y; Yano T; Ueda N; Kawamura S; Ogushi F; Nakamura K
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():181-4. PubMed ID: 6221523
[No Abstract] [Full Text] [Related]
13. Comparison of radioimmunoassay and high-resolution gas chromatography mass spectrometry for the quantitative determination of serum thromboxane B2 and 6-keto-PGF1 alpha after pharmacological blockade of thromboxane synthetase.
Chiabrando C; Castagnoli MN; Noseda A; Fanelli R; Rajtar G; Cerletti C; de Gaetano G
Prostaglandins Leukot Med; 1984 Oct; 16(1):79-88. PubMed ID: 6440153
[TBL] [Abstract][Full Text] [Related]
14. Elevated thromboxane B2 levels during erection.
Bornman MS; du Plessis D; Jacobs DJ; Franz RC
S Afr Med J; 1985 Jun; 67(26):1040. PubMed ID: 3839322
[No Abstract] [Full Text] [Related]
15. Thromboxane, prostaglandin I2 (epoprostenol), and the hemodynamic changes in equine endotoxin shock.
Bottoms GD; Templeton CB; Fessler JF; Johnson MA; Roesel OF; Ewert KM; Adams SB
Am J Vet Res; 1982 Jun; 43(6):999-1002. PubMed ID: 7049018
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of thromboxane biosynthesis in splanchnic ischemia shock.
Oei HH; Zoganas HC; Sakane Y; Robson RD; Glenn TM
Circ Shock; 1986; 18(2):95-106. PubMed ID: 3753907
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney.
Zoja C; Perico N; Corna D; Benigni A; Gabanelli M; Morigi M; Bertani T; Remuzzi G
J Am Soc Nephrol; 1990 Nov; 1(5):799-807. PubMed ID: 2133429
[TBL] [Abstract][Full Text] [Related]
18. [Experimental investigation on the pathogenesis of endotoxin shock--the change of plasma serotonin, histamine, thromboxane B2 and 6-keto PGF1 alpha levels and modulation by indomethacin (author's transl)].
Ishihara Y; Kitamura S; Kosaka K
Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Feb; 20(2):207-13. PubMed ID: 6896537
[No Abstract] [Full Text] [Related]
19. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome.
Zipser RD; Kronborg I; Rector W; Reynolds T; Daskalopoulos G
Gastroenterology; 1984 Dec; 87(6):1228-32. PubMed ID: 6593268
[TBL] [Abstract][Full Text] [Related]
20. A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor.
Carter AJ; Bevan JA; Hanley SP; Morgan WE; Turner DR
Thromb Haemost; 1984 Apr; 51(2):257-60. PubMed ID: 6377567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
